NF EN ISO 14155
Clinical investigation of medical devices for human subjects - Good clinical practice
ISO 14155:2011 addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the safety or performance of medical devices for regulatory purposes. The principles set forth in ISO 14155:2011 also apply to all other clinical investigations and should be followed as far as possible, depending on the nature of the clinical investigation and the requirements of national regulations.ISO 14155:2011 specifies general requirements intended to protect the rights, safety and well-being of human subjects, ensure the scientific conduct of the clinical investigation and the credibility of the results, define the responsibilities of the sponsor and principal investigator, and assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices.ISO 14155:2011 does not apply to in vitro diagnostic medical devices.
ISO 14155:2011 addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the safety or performance of medical devices for regulatory purposes.
The principles set forth in ISO 14155:2011 also apply to all other clinical investigations and should be followed as far as possible, depending on the nature of the clinical investigation and the requirements of national regulations.
ISO 14155:2011 specifies general requirements intended to protect the rights, safety and well-being of human subjects, ensure the scientific conduct of the clinical investigation and the credibility of the results, define the responsibilities of the sponsor and principal investigator, and assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices.
ISO 14155:2011 does not apply to in vitro diagnostic medical devices.
ISO 14155-1:2002 defines procedures for the conduct and performance of clinical investigations of medical devices. It specifies general requirements intended to: protect human subjects;ensure the scientific conduct of the clinical investigation;assist sponsors, monitors, investigators, ethics committees, regulatory authorities and bodies involved in the conformity assessment of medical devices. ISO 14155-1:2002 specifies requirements for the conduct of a clinical investigation such that it establishes the performance of the medical device during the clinical investigation intended to mimic normal clinical use, reveals adverse events under normal conditions of use, and permits assessment of the acceptable risks having regard to the intended performance of the medical device,specifies requirements for the organization, conduct, monitoring, data collection and documentation of the clinical investigation of a medical device,is applicable to all clinical investigation(s) of medical devices whose clinical performance and safety is being assessed in human subjects. ISO 14155-1:2002 is not applicable to in vitro diagnostic medical devices.
This part of EN ISO 14155 provides requirements for the preparation of a Clinical Investigation Plan (CIP) for the clinical investigation of medical devices. The compilation of a CIP in accordance with the requirements of this standard and adherence to it will help in optimising the scientific validity and reproducibility of the results of a clinical investigation. This Standard does not apply to in vitro diagnostic medical devices.
ISO 14155:2011 addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the safety or performance of medical devices for regulatory purposes. The principles set forth in ISO 14155:2011 also apply to all other clinical investigations and should be followed as far as possible, depending on the nature of the clinical investigation and the requirements of national regulations. ISO 14155:2011 specifies general requirements intended to protect the rights, safety and well-being of human subjects, ensure the scientific conduct of the clinical investigation and the credibility of the results, define the responsibilities of the sponsor and principal investigator, and assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices. ISO 14155:2011 does not apply to in vitro diagnostic medical devices.
- Avant-proposv
-
1 Domaine d'application1
-
2 Références normatives1
-
3 Termes et définitions2
-
4 Considérations éthiques8
-
4.1 Généralités8
-
4.2 Influence ou incitation abusives8
-
4.3 Compensation et soins de santé supplémentaires8
-
4.4 Responsabilités8
-
4.5 Communication avec le comité d'éthique8
-
4.6 Populations vulnérables10
-
4.7 Consentement éclairé10
-
5 Planification de l'investigation clinique14
-
5.1 Généralités14
-
5.2 Évaluation des risques14
-
5.3 Justification de la conception de l'investigation clinique15
-
5.4 Plan d'investigation clinique15
-
5.5 Brochure de l'investigateur15
-
5.6 Cahier d'observations16
-
5.7 Plan de surveillance16
-
5.8 Choix du site d'investigation16
-
5.9 Accord(s)16
-
5.10 Étiquetage16
-
5.11 Comité de surveillance des données16
-
6 Conduite d'une investigation clinique17
-
6.1 Généralités17
-
6.2 Initiation du site d'investigation17
-
6.3 Surveillance du site d'investigation17
-
6.4 Événements indésirables et défectuosités du dispositif17
-
6.5 Documents de l'investigation clinique18
-
6.6 Membres supplémentaires de l'équipe du site d'investigation18
-
6.7 Respect de la vie privée du sujet et confidentialité des données18
-
6.8 Maîtrise des documents et des données18
-
6.9 Décompte des dispositifs sous investigation19
-
6.10 Prise en compte des sujets20
-
6.11 Audits20
-
7 Suspension, arrêt et clôture de l'investigation clinique21
-
7.1 Suspension ou arrêt prématuré de l'investigation clinique21
-
7.2 Clôture de routine22
-
7.3 Rapport d'investigation clinique23
-
7.4 Conservation des documents23
-
8 Responsabilités du promoteur24
-
8.1 Assurance qualité et contrôle qualité cliniques24
-
8.2 Planification et conduite de l'investigation clinique24
-
8.3 Délégation externe des tâches et des fonctions30
-
8.4 Communication avec les autorités réglementaires30
-
9 Responsabilités de l'investigateur principal30
-
9.1 Généralités30
-
9.2 Qualifications de l'investigateur principal30
-
9.3 Qualification du site d'investigation31
-
9.4 Communication avec le comité d'éthique31
-
9.5 Processus d'obtention du consentement éclairé31
-
9.6 Conformité avec le plan d'investigation clinique31
-
9.7 Soins médicaux des sujets32
-
9.8 Rapport de sécurité33
- Annexe A (normative) Plan d'investigation clinique34
- Annexe B (normative) Brochure de l'investigateur41
- Annexe C (informative) Cahier d'observations43
- Annexe D (informative) Rapport d'investigation clinique45
- Annexe E (informative) Documents essentiels de l'investigation clinique50
- Annexe F (informative) Catégorisation des événements indésirables58
- Bibliographie61
The Requirements department helps you quickly locate within the normative text:
- mandatory clauses to satisfy,
- non-essential but useful clauses to know, such as permissions and recommendations.
The identification of these types of clauses is based on the document “ISO / IEC Directives, Part 2 - Principles and rules of structure and drafting of ISO documents ”as well as on a constantly enriched list of verbal forms.
With Requirements, quickly access the main part of the normative text!

COBAZ is the simple and effective solution to meet the normative needs related to your activity, in France and abroad.
Available by subscription, CObaz is THE modular solution to compose according to your needs today and tomorrow. Quickly discover CObaz!
Request your free, no-obligation live demo
I discover COBAZ